Predictors of nonadherence among individuals with bipolar disorder receiving treatment in a community mental health clinic
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Background Subjective experience of illness is a critical component of treatment adherence in populations with bipolar disorder (BPD). This cross-sectional analysis examined clinical and subjective variables in relation to adherence in 140 individuals with BPD receiving treatment with mood stabilizing medication. Methods Non-adherence was defined as missing 30% or more of medication on the Tablets Routine Questionnaire (TRQ), a self-reported measure of medication treatment adherence. Adherent and non-adherent groups were compared on measures of attitudes towards illness and treatment including the Attitudes towards Mood Stabilizers Questionnaire (AMSQ), the Insight and Treatment Attitudes Questionnaire (ITAQ), The Rating of Medication Influences (ROMI), and the Multidimensional Health Locus of Control Scale (MHLC). Results Except for substance abuse comorbidity, adherent individuals (N=113, 80.7%) did not differ from non-adherent individuals (N=27, 19.3%) on clinical variables. However, non-adherent individuals had reduced insight into illness, more negative attitudes towards medications, fewer reasons for adherence, and more perceived reasons for non-adherence compared to adherent individuals. The strongest attitudinal predictors for non-adherence were difficulties with medication routines (OR 2.2) and negative attitudes towards drugs in general (OR 2.3). Limitations Results interpretation is limited by cross-sectional design, self-report methodology and sample size. Conclusions Comorbid substance abuse, negative attitudes towards mood stabilizing medication, and difficulty managing to take medication in the context of one's daily schedule are primary determinants of medication treatment adherence. A patient-centered, collaborative model of care that addresses negative attitudes towards medication and difficulty coping with medication routines use may be ideally suited to address individual adherence challenges.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regier, D. A. (1990) · JAMA · doi:10.1001/jama.1990.03450190043026 · Cited by 3,962
Development of the multidimensional health locus of control (MHLC) scales
Wallston, K. A., Strudler Wallston, B., & DeVellis, R. (1978) · Health Education Monographs · doi:10.1177/109019817800600107 · Cited by 3,373 · cited 1×
“Locus of control was assessed with the Multidimensional Locus of Control (MHLC), an 18-item instrument that measures 3 dimensions of locus of control of reinforcement as it pertains to health (internal, external: chance, and external: powerful others) [45].”
MethodKessler, R. C. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830160031005 · Cited by 2,085
New Data from the Addiction Severity Index Reliability and Validity in Three Centers
McLELLAN, A. T., LUBORSKY, L., CACCIOLA, J., GRIFFITH, J., EVANS, F., BARR, H. L., & OʼBRIEN, C. P. (1985) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198507000-00005 · Cited by 1,503
Cooper, L. A., Gonzales, J. J., Gallo, J. J., Rost, K. M., Meredith, L. S., Rubenstein, L. V., Wang, N.-Y., & Ford, D. E. (2003) · Medical Care · doi:10.1097/01.mlr.0000053228.58042.e4 · Cited by 651 · cited 1×
“However, more mutable factors, such as attitudes towards illness and treatments, also contribute to non-adherence, [4, 5,6,7,8,9,10,11,12,13].”
BackgroundGilmer, T. P., Dolder, C. R., Lacro, J. P., Folsom, D. P., Lindamer, L., Garcia, P., & Jeste, D. V. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.4.692 · Cited by 603 · cited 1×
“A number of investigators have defined “good” adherence in seriously mentally ill populations, including those with BPD, as missing no more than 20% of medication [29,30,31], while Scott and Pope [14] have derived a clinically relevant definition of poor adherence in BPD as missing 30% or more of medications as identi…”
BackgroundTreatment preferences among depressed primary care patients
Dwight-Johnson, M., Sherbourne, C. D., Liao, D., & Wells, K. B. (2000) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2000.08035.x · Cited by 478 · cited 1×
“However, more mutable factors, such as attitudes towards illness and treatments, also contribute to non-adherence, [4, 5,6,7,8,9,10,11,12,13].”
BackgroundNonadherence With Mood Stabilizers: Prevalence and Predictors
Scott, J., & Pope, M. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0502 · Cited by 315
Collaborative care for bipolar disorder, Part II: impact on clinical outcome, function, and costs.
Bauer, M. S., McBride, L., Williford, W. O., Glick, H., Kinosian, B., Altshuler, L., Beresford, T., Kilbourne, A. M., & Sajatovic, M. (2006) · Psychiatric Services · doi:10.1176/ps.2006.57.7.937 · Cited by 312
Self-citationThe Lifetime Cost of Bipolar Disorder in the US: An Estimate for New Cases in 1998
Begley, C. E., Annegers, J. F., Swann, A. C., Lewis, C., Coan, S., Schnapp, W. B., & Bryant-Comstock, L. (2001) · PharmacoEconomics · doi:10.2165/00019053-200119050-00004 · Cited by 265
Cited by
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Beaulieu, S., Alda, M., O’Donovan, C., MacQueen, G., McIntyre, R. S., Sharma, V., et al. (2013) · Bipolar Disorders · doi:10.1111/bdi.12025 · Cited by 1,217
Náfrádi, L., Nakamoto, K., & Schulz, P. J. (2017) · PLOS ONE · doi:10.1371/journal.pone.0186458 · Cited by 543
Holmes, E. A. F., Hughes, D. A., & Morrison, V. L. (2014) · Value in Health · doi:10.1016/j.jval.2014.08.2671 · Cited by 199
Mood disorders medications: predictors of nonadherence – review of the current literature
Pompili, M., Venturini, P., Palermo, M., Stefani, H., Seretti, M. E., Lamis, D. A., Serafini, G., Amore, M., & Girardi, P. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2013.811976 · Cited by 120
Sylvia, L. G., Hay, A., Ostacher, M. J., Miklowitz, D. J., Nierenberg, A. A., Thase, M. E., Sachs, G. S., Deckersbach, T., & Perlis, R. H. (2013) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3182900c6f · Cited by 62
“It is also likely that individual, patient factors, such as impulsivity, poor insight, denial of illness, and negative attitude toward medication, explain part of (ie, moderate) this relationship.(14,45,46) Notably, the patients’ perceived strength of the relationship and degree of collaboration with their psychiatris…”
BackgroundBrown, E. S., Todd, J. P., Hu, L. T., Schmitz, J. M., Carmody, T. J., Nakamura, A., Sunderajan, P., Rush, A. J., Adinoff, B., Bret, M. E., et al. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.14070857 · Cited by 36
Maremmani, A. G. I., Rovai, L., Bacciardi, S., Rugani, F., Pacini, M., Paolo Pani, P., Osso, L. D., Akiskal, H., & Maremmani, I. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.06.054 · Cited by 35
Treatment adherence in bipolar disorder
Savas, H., Unal, A., & Virit, O. (2011) · Journal of Mood Disorders · doi:10.5455/jmood.20110827015615 · Cited by 17
Participation in decision-making about medication: A qualitative analysis of medication adherence
Inder, M., Lacey, C., & Crowe, M. (2019) · International Journal of Mental Health Nursing · doi:10.1111/inm.12516 · Cited by 16
Metadata
- Authors
- Sajatovic, M., Ignacio, R. V., West, J. A., Cassidy, K. A., Safavi, R., Kilbourne, A. M., & Blow, F. C.
- Venue
- Comprehensive Psychiatry
- Publisher
- Elsevier BV
- Published
- 2009-03
- Volume
- 50
- Issue
- 2
- Pages
- 100-107
- ISSN
- 0010-440X (ISSN-L)
- OpenAlex
- W2103293299
- Cited by
- 139
- References
- 16
- FWCI
- 5.43
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.